Rhabdomyosarcoma with widespread bone marrow infiltration: Beneficial management role of F-18 FDG PET

Clinical Nuclear Medicine

Volumn 32, Issue 10, 2007, Pages 787-789

  Seshadri, Nagabushan ^a   Wright, Penny ^a   Balan, Kottekkattu K ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

18F FDGPET; Alveolar rhabdomyosarcoma; Bone marrow; Metastatic

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ARTICLE; BONE MARROW; BONE MARROW METASTASIS; CANCER DIAGNOSIS; CASE REPORT; DRUG UPTAKE; FEMALE; HUMAN; POSITRON EMISSION TOMOGRAPHY; RHABDOMYOSARCOMA;

ADOLESCENT; BONE MARROW NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RHABDOMYOSARCOMA, ALVEOLAR;

EID: 34748837270     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318148b434     Document Type: Article

References (12)

1. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med. 1999;341:342-345.
2. Maywald O, Metzgeroth G, Schoch C, et al. Alveolar rhabdomyosarcoma with bone marrow infiltration mimicking haematological neoplasia. Br J Haematol. 2002;119:583.
3. Daldrup-Link HE, Franzius C, Link TM, et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol. 2001;177:229-236.
4. McCarville MB, Christie R, Daw NC, et al. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol. 2005;184:1293-1304.
5. Ben Arush MW, Bar Shalom R, Postovsky S, et al. Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities. J Pediatr Hematol Oncol. 2006;28:440-445.
6. Sugawara Y, Fisher SJ, Zasadny KR, et al. Preclinical and clinical studies of bone marrow uptake of fluorine-18-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol. 1998;16:173-180.
7. Blodgett TM, Ames JT, Torok FS, et al. Diffuse bone marrow uptake on whole-body F-18 fluorodeoxyglucose positron emission tomography in a patient taking recombinant erythropoietin. Clin Nucl Med. 2004;29:161-163.
8. Takalkar A, Yu JQ, Kumar R, et al. Diffuse bone marrow accumulation of FDG in a patient with chronic myeloid leukemia mimics hematopoietic cytokine-mediated FDG uptake on positron emission tomography. Clin Nucl Med. 2004;29:637-639.
9. Chiang SB, Rebenstock A, Guan L, et al. Diffuse bone marrow involvement of Hodgkin lymphoma mimics haemopoetic cytokine-mediated FDG uptake on FDG PET imaging. Clin Nucl Med. 2003;28:674-676.
10. Aflalo-Hazan V, Gutman F, Kerrou K, et al. Increased FDG uptake by bone marrow in major beta-thalassemia. Clin Nucl Med. 2005;30:754-755.
11. Inoue K, Okada K, Harigae H, et al. Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes. Clin Nucl Med. 2006;31:721-723.
12. Burrell SC, Fischman AJ. Myelofibrosis on F-18 FDG PET Imaging. Clin Nucl Med. 2005;30:674.